FUJIFILM Wako Pure Chemical Corporation

FUJIFILM Wako Pure Chemical Corporation is a provider of GLP-compliant safety studies based in Medford, with extensive experience in non-clinical testing. This section introduces the company’s features in non-clinical studies, examples of disease models, and case studies. We hope you can use this information as a reference when selecting a reliable partner for your non-clinical studies.

Features of FUJIFILM Wako Pure Chemical Corporation’s Contract Non-Clinical Study Services

Comprehensive pharmacological studies across a wide range of disease areas

FUJIFILM Wako Pure Chemical Corporation provides pharmacological efficacy studies covering a broad spectrum of disease areas, including the neurology, cardiovascular, metabolic, and respiratory, digestive system, renal and urinary systems, allergy, inflammation, immune systems, and immuno oncology. The company also offers in vitro Magnus assays to accommodate diverse testing needs for different drug development stages. They are GLP compliant; offering comprehensive support throughout early discovery to later drug development.

Pharmacokinetic studies compliant with GLP and reliability standards

FUJIFILM Wako Pure Chemical Corporation has established a robust platform for pharmacokinetic (PK) studies with Good Laboratory Practice (GLP) and reliability standards. They offer in vivo study for absorption, distribution, metabolism, and excretion (ADME) of drug candidates. They thrive to deliver precise pharmacokinetic data to support each stage of drug development and ensure smooth transition to clinical stage.

High-quality safety studies backed by advanced analytical technologies

The company also provide high-quality safety /toxicity study and mutagenicity study. You can determine initial human doses and safe dose ranges by clarifying target organs, dose dependency, exposure relationships, and recovery potential. Leveraging analytical and bio-related technologies cultivated over many years, they offer in vivo study and a wide range of analytical service.

Contract Research Partners with FUJIFILM Wako Pure Chemical Corporation

Kamakura Techno-Science Co., Ltd.

Kamakura Techno-Science is a contract research organization who provides safety and pharmacological evaluations. They utilize bio-related technologies developed in Toray’s life science business. The company conducts a wide variety of studies in neurological, cardiovascular, metabolic, respiratory, gastrointestinal, renal/urinary, and allergic, inflammatory,and autoimmune related.

Fukushima Cell Factory Co., Ltd.

Fukushima Cell Factory offers research support services for drug development by utilizing technologies and expertise cultivated through the Fukushima Pharmaceutical Industry Support Project. Services include cell and specimen storage, cell culture, cell characterization, and cell sorting.

Non-Clinical Model at FUJIFILM Wako Pure Chemical Corporation

In vitro (ex vivo) study using F-PDX® (Patient-Derived Tumor Xenograft)

Fukushima Pharmaceutical Industry has developed Tumor-bearing animal model that maintains original tumor’s histopathology and gene expression characteristics. This model is suited for evaluating immuno-oncology indications by transplanting the PDX into immunodeficient mice. Ex vivo testing is also available without transplantation, enabling direct evaluation of drug efficacy.

Pharmacological study using cerebral infarction (cerebral ischemia) models

This model is induced by cerebral ischemia with middle cerebral artery occlusion and bilateral common carotid artery ligation. Rats are used, and reports are typically delivered within one month.

Company Information

FUJIFILM Wako Pure Chemical Corporation offers a wide range of development support services, including drug discovery, regenerative medicine, and gene therapy.